| LDR | | 01882nam u200409 4500 |
| 001 | | 000000422866 |
| 005 | | 20190215170455 |
| 008 | | 181129s2017 |||||||||||||||||c||eng d |
| 020 | |
▼a 9780438313231 |
| 035 | |
▼a (MiAaPQ)AAI10618754 |
| 035 | |
▼a (MiAaPQ)mayo:10455 |
| 040 | |
▼a MiAaPQ
▼c MiAaPQ
▼d 247004 |
| 082 | 0 |
▼a 612 |
| 100 | 1 |
▼a Gonzalez Porras, Maria A. |
| 245 | 10 |
▼a Mesoporous Silica Nanoparticles to Target Motoneurons. |
| 260 | |
▼a [S.l.]:
▼b College of Medicine - Mayo Clinic.,
▼c 2017. |
| 260 | 1 |
▼a Ann Arbor:
▼b ProQuest Dissertations & Theses,
▼c 2017. |
| 300 | |
▼a 225 p. |
| 500 | |
▼a Source: Dissertation Abstracts International, Volume: 80-01(E), Section: B. |
| 500 | |
▼a Adviser: Carlos B. Mantilla. |
| 502 | 1 |
▼a Thesis (Ph.D.)--College of Medicine - Mayo Clinic, 2017. |
| 520 | |
▼a Drug delivery systems to motoneurons are critical in developing effective and safe treatments for motoneuron diseases (e.g. amyotrophic lateral sclerosis), as well as in understanding causes of muscle denervation (e.g. spinal cord injury, or age |
| 520 | |
▼a The use of nanoparticles to target the delivery of drugs can potentially ameliorate a number of problems exhibited by conventional 'free' drugs, including poor solubility, limited stability, rapid clearing, and, in particular, lack of selectivit |
| 590 | |
▼a School code: 1542. |
| 650 | 4 |
▼a Physiology. |
| 650 | 4 |
▼a Nanoscience. |
| 690 | |
▼a 0719 |
| 690 | |
▼a 0565 |
| 710 | 20 |
▼a College of Medicine - Mayo Clinic.
▼b Biomedical Engineering. |
| 773 | 0 |
▼t Dissertation Abstracts International
▼g 80-01B(E). |
| 773 | |
▼t Dissertation Abstract International |
| 790 | |
▼a 1542 |
| 791 | |
▼a Ph.D. |
| 792 | |
▼a 2017 |
| 793 | |
▼a English |
| 856 | 40 |
▼u http://www.riss.kr/pdu/ddodLink.do?id=T14996639
▼n KERIS
▼z 이 자료의 원문은 한국교육학술정보원에서 제공합니다. |
| 980 | |
▼a 201812
▼f 2019 |
| 990 | |
▼a ***1012033 |